|Test||HERPES SIMPLEX VIRUS (HSV), DNA|
|Methodology||Real-Time Polymerase Chain Reaction (PCR)
This test replaces Culture Virus HSV.
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
|Description||Useful for detection of HSV-1 and HSV-2 DNA in CSF, blood, and other specimens
This test was developed and its performance characteristics determined by NorDx. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not required. The diagnostic utility for this test has been validated by NorDx. This test is used for clinical purposes, and should not be regarded as investigational or for research use only.
|Specimen||SUBMIT ONLY ONE OF THE FOLLOWING SPECIMENS:
CEREBROSPINAL FLUID (CSF)
DERMAL, GENITAL, THROAT AND ORAL SPECIMENS
|Reference Values||HSV-1 and HSV-2 not detected.
Positive results reported as:
or HSV-1 and HSV-2 detected
A positive result on a CSF specimen is a critical value with auto call-back.
|Analytic Time||1 Day; Maximum Laboratory Time - 5 Days (Swabs) - 2 Days (CSF)|
|Day(s) Test Set Up||CSF: Monday through Saturday. Other specimens: Monday, Wednesday and Friday|